Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $46.66

0.53 (+1.15%)

POWR Rating

Component Grades














  • Value is the dimension where PFE ranks best; there it ranks ahead of 96.36% of US stocks.
  • The strongest trend for PFE is in Stability, which has been heading up over the past 179 days.
  • PFE's current lowest rank is in the Momentum metric (where it is better than 17.51% of US stocks).

PFE Stock Summary

  • With a market capitalization of $256,821,218,780, PFIZER INC has a greater market value than 99.53% of US stocks.
  • PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 93.28% of US equities in our set.
  • In terms of volatility of its share price, PFE is more volatile than just 9.52% of stocks we're observing.
  • Stocks that are quantitatively similar to PFE, based on their financial statements, market capitalization, and price volatility, are LLY, MRK, ABBV, NVO, and BABA.
  • PFE's SEC filings can be seen here. And to visit PFIZER INC's official web site, go to

PFE Valuation Summary

  • PFE's EV/EBIT ratio is 9.4; this is 12.96% lower than that of the median Healthcare stock.
  • PFE's price/sales ratio has moved down 3.1 over the prior 243 months.

Below are key valuation metrics over time for PFE.

Stock Date P/S P/B P/E EV/EBIT
PFE 2022-09-01 2.6 3.0 8.9 9.4
PFE 2022-08-31 2.5 2.9 8.7 9.1
PFE 2022-08-30 2.5 3.0 8.8 9.2
PFE 2022-08-29 2.6 3.0 8.9 9.3
PFE 2022-08-26 2.6 3.0 9.0 9.4
PFE 2022-08-25 2.7 3.1 9.2 9.6

PFE Growth Metrics

    Its 5 year net income to common stockholders growth rate is now at 155.39%.
  • Its 3 year net cashflow from operations growth rate is now at 122.51%.
  • Its year over year revenue growth rate is now at 107.75%.
PFE's revenue has moved up $39,328,000,000 over the prior 30 months.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-03-31 92,367 34,583 24,966
2021-12-31 81,288 32,580 21,979
2021-09-30 63,600 32,291 19,180
2021-06-30 51,637 23,552 13,228
2021-03-31 44,461 15,808 11,091
2020-12-31 41,908 14,403 9,616

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
  • XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.312 0.704 0.149
2021-04-04 0.265 0.763 0.116
2020-12-31 0.247 0.793 0.099
2020-09-27 0.282 0.799 0.083
2020-06-28 0.288 0.799 0.181
2020-03-29 0.307 0.799 0.200

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.03 Average Broker Recommendation 1.8 (Hold)

PFE Stock Price Chart Interactive Chart >

Price chart for PFE

PFE Price/Volume Stats

Current price $46.66 52-week high $61.71
Prev. close $46.13 52-week low $40.94
Day low $45.87 Volume 3,448,967
Day high $46.74 Avg. volume 25,981,115
50-day MA $49.80 Dividend yield 3.47%
200-day MA $51.59 Market Cap 261.87B

Pfizer Inc. (PFE) Company Bio

Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.

U.K. to begin rollout of new COVID vaccination campaign

The U.K. will begin its autumn COVID-19 vaccination campaign in the coming weeks after authorizing booster shots made by Pfizer and Moderna that have been modified to target both the original virus and the widely circulating omicron variant.

Yahoo | September 3, 2022

Moderna Has One Over Pfizer/BioNTech – but It’s Nothing to Do With Patent Infringement

BioNTech’s offering violates….

Marty Shtrubel on TipRanks | September 2, 2022

5 Cheap Retirement Stocks to Buy Now for Your Golden Years

Planning for your golden years doesn’t have to command onerous premiums as these cheap retirement stocks to buy now confirm.

Josh Enomoto on InvestorPlace | September 2, 2022

6 No-Brainer Forever Stocks to Buy if You Have Money to Invest

If you’re patiently investing for the long haul, certain relevant companies may qualify for no-brainer forever stocks to buy.

Josh Enomoto on InvestorPlace | September 2, 2022

Pfizer, Moderna Dip Despite CDC Green-Light For Updated Covid Shots

The CDC green-lighted updated Covid booster shots from Pfizer with BioNTech and Moderna, but vaccine stocks largely dipped Friday.

Yahoo | September 2, 2022

Read More 'PFE' Stories Here

PFE Price Returns

1-mo -6.27%
3-mo -5.90%
6-mo -5.70%
1-year 3.60%
3-year 49.51%
5-year 73.36%
YTD -19.11%
2021 66.69%
2020 3.23%
2019 -6.91%
2018 24.82%
2017 15.90%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6279 seconds.